Madrigal Pharmaceuticals, Inc. Share Price
NASDAQ: MDGL | Mid CapMadrigal Pharmaceuticals, Inc. Stock Performance
Madrigal Pharmaceuticals, Inc. Share Price Today
As of 30 October 2026, Madrigal Pharmaceuticals, Inc.'s share price is $431.28. The stock opened at $440.05, compared to its previous close of $430.89. During today's trading session, Madrigal Pharmaceuticals, Inc.'s share price traded between $427.67 and $445.45, with an average price of $436.56. Over the past 52 weeks, the stock has recorded a high of $614.13 and a low of $393.82. In terms of performance, Madrigal Pharmaceuticals, Inc.'s share price has declined by 16.51% over the last six months and is up 2.90% on a year-on-year basis.
Madrigal Pharmaceuticals, Inc. Share Price Chart
Madrigal Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Madrigal Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Madrigal Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $503.21 | $431.65 | -14.32% |
Sep 2026 | $544.35 | $503.77 | -7.30% |
Aug 2026 | $468.70 | $543.45 | +16.19% |
Jul 2026 | $535.50 | $467.72 | -12.88% |
Jun 2026 | $494.44 | $536.85 | +8.03% |
May 2026 | $514.33 | $496.94 | -3.79% |
Apr 2026 | $544.66 | $516.53 | -1.27% |
Mar 2026 | $429.31 | $523.17 | +21.08% |
Feb 2026 | $486.09 | $432.09 | -11.58% |
Jan 2026 | $582.02 | $488.67 | -16.10% |
Dec 2025 | $591.94 | $582.42 | -2.46% |
Nov 2025 | $420.95 | $597.12 | +42.47% |